1. ALLA AKTIER
  2. NYHETER
  3. MEDIVIR

Medivir

Nyheter Medivir Nyheter alla bolag

BioStock: Medivir presents promising results in difficult-to-treat patient population

– We are particularly encouraged by the durable benefit, with patients remaining on treatment for much longer than expected. More than 10 months median time to progression is significantly longer than previously achieved with second-line treatment with Lenvima monotherapy or other treatment options, says Medivir's CEO Jens Lindberg.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/06/medivir-presents-promising-results-in-difficult-to-treat-patient-population/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Datum 2024-06-27, kl 10:00
Källa Cision
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.